285 related articles for article (PubMed ID: 6790606)
1. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.
Jennings HJ; Lugowski C
J Immunol; 1981 Sep; 127(3):1011-8. PubMed ID: 6790606
[TBL] [Abstract][Full Text] [Related]
2. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.
Jennings HJ; Roy R; Gamian A
J Immunol; 1986 Sep; 137(5):1708-13. PubMed ID: 3091688
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of two types of meningococcal group C polysaccharide conjugates using tetanus toxoid as carrier protein.
Beuvery EC; Roy R; Kanhai V; Jennings HJ
Dev Biol Stand; 1986; 65():197-204. PubMed ID: 3104115
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
[TBL] [Abstract][Full Text] [Related]
5. Analytical, toxicological and immunological consequences of the use of N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide as coupling reagent for the preparation of meningococcal group C polysaccharide-tetanus toxoid conjugate as vaccine for human use.
Beuvery EC; Speijers GJ; Lutz BI; Freudenthal D; Kanhai V; Haagmans B; Derks HJ
Dev Biol Stand; 1986; 63():117-28. PubMed ID: 3091432
[TBL] [Abstract][Full Text] [Related]
6. New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization.
Cuello M; Cabrera O; Martinez I; Del Campo JM; Camaraza MA; Sotolongo F; Pérez O; Sierra G
Vaccine; 2007 Feb; 25(10):1798-805. PubMed ID: 17240485
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice.
Peeters CC; Tenbergen-Meekes AM; Evenberg DE; Poolman JT; Zegers BJ; Rijkers GT
J Immunol; 1991 Jun; 146(12):4308-14. PubMed ID: 2040803
[TBL] [Abstract][Full Text] [Related]
8. Preparation and immunochemical characterization of meningococcal group C polysaccharide-tetanus toxoid conjugates as a new generation of vaccines.
Beuvery EC; Miedema F; van Delft R; Haverkamp J
Infect Immun; 1983 Apr; 40(1):39-45. PubMed ID: 6187693
[TBL] [Abstract][Full Text] [Related]
9. Unique intermolecular bactericidal epitope involving the homosialopolysaccharide capsule on the cell surface of group B Neisseria meningitidis and Escherichia coli K1.
Jennings HJ; Gamian A; Michon F; Ashton FE
J Immunol; 1989 May; 142(10):3585-91. PubMed ID: 2469720
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid.
Granoff DM; Bartoloni A; Ricci S; Gallo E; Rosa D; Ravenscroft N; Guarnieri V; Seid RC; Shan A; Usinger WR; Tan S; McHugh YE; Moe GR
J Immunol; 1998 May; 160(10):5028-36. PubMed ID: 9590252
[TBL] [Abstract][Full Text] [Related]
11. Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.
Southern J; Deane S; Ashton L; Borrow R; Goldblatt D; Andrews N; Balmer P; Morris R; Kroll JS; Miller E
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1100-4. PubMed ID: 15539513
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.
Wessels MR; Paoletti LC; Kasper DL; DiFabio JL; Michon F; Holme K; Jennings HJ
J Clin Invest; 1990 Nov; 86(5):1428-33. PubMed ID: 2243123
[TBL] [Abstract][Full Text] [Related]
13. Immunological evaluation of meningococcal group C polysaccharide-tetanus toxoid conjugate in mice.
Beuvery EC; van Delft RW; Miedema F; Kanhai V; Nagel J
Infect Immun; 1983 Aug; 41(2):609-17. PubMed ID: 6409811
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide.
Bartoloni A; Norelli F; Ceccarini C; Rappuoli R; Costantino P
Vaccine; 1995 Apr; 13(5):463-70. PubMed ID: 7543714
[TBL] [Abstract][Full Text] [Related]
15. Activity and cross-reactivity of antibodies induced in mice by immunization with a group B meningococcal conjugate.
Coquillat D; Bruge J; Danve B; Latour M; Hurpin C; Schulz D; Durbec P; Rougon G
Infect Immun; 2001 Nov; 69(11):7130-9. PubMed ID: 11598089
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ
Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical and immunological characterization of meningococcal group A polysaccharide-tetanus toxoid conjugates prepared by two methods.
Beuvery EC; vd Kaaden A; Kanhai V; Leussink AB
Vaccine; 1983 Dec; 1(1):31-6. PubMed ID: 6442499
[TBL] [Abstract][Full Text] [Related]
18. Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates.
Paoletti LC; Kasper DL; Michon F; DiFabio J; Jennings HJ; Tosteson TD; Wessels MR
J Clin Invest; 1992 Jan; 89(1):203-9. PubMed ID: 1729272
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
[TBL] [Abstract][Full Text] [Related]
20. Conjugation of meningococcal lipopolysaccharide R-type oligosaccharides to tetanus toxoid as route to a potential vaccine against group B Neisseria meningitidis.
Jennings HJ; Lugowski C; Ashton FE
Infect Immun; 1984 Jan; 43(1):407-12. PubMed ID: 6418661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
